Log In
BCIQ
Print this Print this
 

TG01

  Manage Alerts
Collapse Summary General Information
Company Targovax A/S
DescriptionPeptide vaccine targeting Ras mutations associated with cancer
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationPancreatic cancer
Indication DetailsTreat operable pancreatic cancer; Treat pancreatic cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$29.8M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/02/2015

$29.8M

0

0

Get a free BioCentury trial today